We serve as outside general counsel for Tyba, an early stage technology company providing a platform for renewable energy companies and investors. We advise the company on a wide range of matters, including technology agreements, entity structure, capital raising, equity incentives and shareholding.
Outside General Counsel for an Early Stage Technology Company
Client Type: Private Company
You Also May Be Interested In:
-
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
-
Represented Boston Children’s Hospital with intellectual property, business, and government contracting issues associated with VaccineFinder
-
We represented Tractor Supply Company (Nasdaq: TSCO) in their agreement to acquire Orscheln Farm and Home, a family-owned farm and ranch retailer.